LAB
INDEX
Showing search results for "Blood Vessel"
Impact
Papers
Jobs
Conferences
Name
Impact
?
Papers
Institution
Country
Funding
Alitalo, Kari
426
23
University of Helsinki
Finland
-
Carmeliet, P
256.3
17
Vesalius Research Center, KU Leuven, Leuven
Belgium
-
Detmar, Michael
250.3
26
Swiss Federal Institute of Technology
Switzerland
$155,925.00
Jain, Rakesh K
176.9
14
Massachusetts General Hospital and Harvard Medical School
USA
$27,849,572.00
Ferrara, Napoleone
166.5
17
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
USA
-
Koh, Gou Young
161.2
11
Korea Advanced Institute of Science and Technology
Korea
-
Cao, Yihai
156.6
16
Karolinska Institute
Sweden
-
McDonald, Donald M
146.5
15
University of California
USA
$4,413,923.00
Kahn, Mark L
117.5
6
University of Pennsylvania
USA
$10,106,623.00
Adams, Ralf H
117.1
5
Cancer Research UK London Research Institute
UK
-
Johnson, Randall S
94.4
7
University of California
USA
-
Ylä-Herttuala, S
88
19
University of Eastern Finland
Finland
-
Zhang, Yun
87.8
22
Shandong University
China
$3,191,119.00
Mercurio, Arthur M
87.1
5
University of Massachusetts Medical School
USA
$5,785,281.00
Choueiri, Toni K
85.8
8
Stanford University School of Medicine
USA
-
Simons, Michael
79.8
7
Yale University School of Medicine
USA
$16,608,443.00
Popel, Aleksander S
77.2
16
Johns Hopkins University School of Medicine
USA
$7,879,505.00
Petrova, Tatiana V
74.5
4
Molecular and Cancer Biology Program, Biomedicum Helsinki, Helsinki
Finland
-
Stacker, Steven A
72.8
5
Royal Melbourne Hospital
Australia
-
Ambati, Jayakrishna
71.7
2
Departments of Ophthalmology & Visual Sciences, Lexington, Kentucky
USA
$7,853,201.00
Hodivala-Dilke, Kairbaan M
71.3
7
Bart's & The London Queen Mary's School of Medicine & Dentistry
UK
-
Luo, Yongzhang
70.5
11
Tsinghua University
China
-
Ruhrberg, Christiana
70.4
10
University College London
UK
-
Van Cutsem, Eric
67.1
4
University of Chicago Comprehensive Cancer Center
USA
-
Ellis, Lee M
64.9
7
The University of Texas MD Anderson Cancer Center
USA
$1,977,594.00
Ribatti, Domenico
64.9
16
University of Bari Medical School
Italy
-
Fu, Yang-Xin
64.9
1
Chinese Academy of Sciences
China
$6,786,107.00
D'Amore, Patricia A
61.6
12
Schepens Eye Research Institute/Massachusett Eye and Ear
USA
-
Chen, Xiaoyuan
60.9
12
Stanford University School of Medicine
USA
$14,363,192.00
Schwartz, Martin A
58.6
2
N/A
$9,451,470.00
Heymach, John V
58.1
6
The University of Texas M. D. Anderson Cancer Center
USA
$848,140.00
Kiefer, Friedemann
57.8
3
Max Planck Institute for Molecular Biomedicine
Germany
-
Dai, Jianwu
57.6
9
Chinese Academy of Sciences
China
-
Hong, Yong-Kil
56.9
5
The Catholic University of Korea
Korea
-
Oliver, Guillermo
56.5
4
Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105
USA
$5,733,624.00
Punt, Cornelis J A
55.6
2
Radboud University Nijmegen Medical Center
Netherlands
-
Kerbel, Robert S
55.6
3
University of Toronto
USA
$962,085.00
Dvorak, Harold F
53.9
8
Harvard Medical School
USA
-
Brady, Mark F
53.3
1
Fox Chase Cancer Center
USA
-
Gilman, Andrew L
53.3
1
and Moores Cancer Center
USA
-
Komatsu, Masanobu
53.1
1
Sanford-Burnham Medical Research Institute at Lake Nona
USA
$2,193,064.00
Lammert, Eckhard
52.6
5
Heinrich-Heine-University
Germany
-
Motzer, Robert J
52.5
5
Pfizer Oncology, 10646 Science Center Drive, La Jolla, San Diego, CA, 92121
USA
$1,377,352.00
Liu, Mingyao
50.3
8
East China Normal University
China
$1,661,352.00
Yoon, Young-sup
49.2
2
Emory University School of Medicine
USA
$9,568,558.00
Lemström, Karl B
49.1
2
FI-00014 University of Helsinki and Helsinki University Central Hospital
Finland
-
Wang, Yizheng
48.9
14
Second Military Medical University
China
-
Mooney, David J
47.8
6
Harvard University
USA
$13,796,290.00
Bautch, Victoria L
47.5
6
The University of North Carolina at Chapel Hill
USA
$3,977,091.00
Sood, Anil K
46.7
5
University of Texas M.D. Anderson Cancer Center
USA
$21,735,597.00
Name
Institution
Date
Impact
Publication
Brady, Mark F
Fox Chase Cancer Center
12/29/2011
53.29
The New England journal of medicine
Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Abstract
Gilman, Andrew L
and Moores Cancer Center
09/30/2010
53.29
The New England journal of medicine
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
Abstract
Punt, Cornelis J A
Radboud University Nijmegen Medical Center
02/06/2009
53.29
The New England journal of medicine
Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.
Abstract
Alitalo, Kari
University of Helsinki
02/23/2009
39.12
Nature reviews. Molecular cell biology
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
Abstract
Schwartz, Martin A
University of Virginia
02/06/2009
39.12
Nature reviews. Molecular cell biology
Mechanotransduction in vascular physiology and atherogenesis.
Abstract
Motzer, Robert J
Pfizer Oncology, 10646 Science Center Drive, La Jolla, San Diego, CA, 92121
11/04/2011
38.27
Lancet
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.
Abstract
Mercurio, Arthur M
University of Massachusetts Medical School
11/22/2013
37.54
Nature reviews. Cancer
VEGF targets the tumour cell.
Abstract
McDonald, Donald M
University of California
09/24/2012
37.54
Nature reviews. Cancer
Controlling escape from angiogenesis inhibitors.
Abstract
Adams, Ralf H
Cancer Research UK London Research Institute
03/18/2012
36.28
Nature
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
Abstract
Adams, Ralf H
Cancer Research UK London Research Institute
06/01/2010
36.28
Nature
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
09/17/2009
36.28
Nature
VEGFR1-activity-independent metastasis formation.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
03/04/2013
32.40
Cell
Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
04/07/2010
32.40
Cell
PlGF blockade does not inhibit angiogenesis during primary tumor growth.
Abstract
Carmeliet, Peter
University of Leuven
04/07/2010
32.40
Cell
Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.
Abstract
Alitalo, Kari
University of Helsinki
02/24/2010
32.40
Cell
Lymphangiogenesis: Molecular mechanisms and future promise.
Abstract
Carmeliet, Peter
University of Leuven
04/03/2009
26.86
Physiological reviews
Role and therapeutic potential of VEGF in the nervous system.
Abstract
Kahn, Mark L
University of Pennsylvania
07/12/2013
26.56
Cancer cell
Platelets and tumor cells: a new form of border control.
Abstract
Komatsu, Masanobu
Sanford-Burnham Medical Research Institute at Lake Nona
08/17/2012
26.56
Cancer cell
Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels.
Abstract
Stacker, Steven A
Royal Melbourne Hospital
02/20/2012
26.56
Cancer cell
VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.
Abstract
Johnson, Randall S
University of California
01/23/2012
26.56
Cancer cell
Endothelial cell HIF-1α and HIF-2α differentially regulate metastatic success.
Abstract
Carmeliet, Peter
University of Leuven
06/13/2011
26.56
Cancer cell
Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia.
Abstract
Carmeliet, Peter
University of Leuven
01/06/2011
26.56
Cancer cell
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.
Abstract
McDonald, Donald M
University of California
12/15/2010
26.56
Cancer cell
New antibody to stop tumor angiogenesis and lymphatic spread by blocking receptor partnering.
Abstract
Alitalo, Kari
University of Helsinki
12/02/2010
26.56
Cancer cell
Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
08/16/2010
26.56
Cancer cell
Double antiangiogenic protein, DAAP, targeting VEGF-A and angiopoietins in tumor angiogenesis, metastasis, and vascular leakage.
Abstract
Sood, Anil K
University of Texas M.D. Anderson Cancer Center
08/16/2010
26.56
Cancer cell
Regulation of tumor angiogenesis by EZH2.
Abstract
Johnson, Randall S
University of California
06/14/2010
26.56
Cancer cell
Tumor vessels are Eph-ing complicated.
Abstract
Mercurio, Arthur M
University of Massachusetts Medical School
04/13/2010
26.56
Cancer cell
ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.
Abstract
Carmeliet, Peter
University of Leuven
03/02/2009
26.56
Cancer cell
Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited.
Abstract
Kerbel, Robert S
University of Toronto
03/02/2009
26.56
Cancer cell
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.
Abstract
Kerbel, Robert S
University of Toronto
12/29/2008
26.56
Cancer cell
Tumor-associated fibroblasts as "Trojan Horse" mediators of resistance to anti-VEGF therapy.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
12/29/2008
26.56
Cancer cell
PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.
Abstract
Choueiri, Toni K
Stanford University School of Medicine
08/08/2012
22.58
The Lancet. Oncology
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.
Abstract
Van Cutsem, Eric
University of Chicago Comprehensive Cancer Center
05/17/2012
22.58
The Lancet. Oncology
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials.
Abstract
Van Cutsem, Eric
University of Chicago Comprehensive Cancer Center
03/07/2011
22.58
The Lancet. Oncology
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.
Abstract
Ellis, Lee M
The University of Texas MD Anderson Cancer Center
02/18/2010
22.58
The Lancet. Oncology
Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
08/04/2013
22.46
Nature medicine
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy.
Abstract
Alitalo, Kari
University of Helsinki
11/07/2011
22.46
Nature medicine
The lymphatic vasculature in disease.
Abstract
Ambati, Jayakrishna
Departments of Ophthalmology & Visual Sciences, Lexington, Kentucky
08/09/2009
22.46
Nature medicine
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.
Abstract
Hodivala-Dilke, Kairbaan M
Queen Mary University of London
03/22/2009
22.46
Nature medicine
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.
Abstract
Kahn, Mark L
University of Pennsylvania
01/18/2009
22.46
Nature medicine
Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway.
Abstract
Fu, Yang-Xin
Chinese Academy of Sciences
01/28/2011
21.63
Immunity
Deflating the lymph node.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
01/20/2011
21.63
Immunity
T lymphocytes negatively regulate lymph node lymphatic vessel formation.
Abstract
Adams, Ralf H
Cancer Research UK London Research Institute
01/27/2013
19.48
Nature cell biology
Spatial regulation of VEGF receptor endocytosis in angiogenesis.
Abstract
Schwartz, Martin A
10/03/2012
19.48
Nature cell biology
Profilin phosphorylation as a VEGFR effector in angiogenesis.
Abstract
Alitalo, Kari
University of Helsinki
09/11/2011
19.48
Nature cell biology
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.
Abstract
Van Cutsem, Eric
University of Chicago Comprehensive Cancer Center
09/10/2012
18.37
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).
Abstract
Choueiri, Toni K
Stanford University School of Medicine
02/06/2012
18.37
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
05/10/2010
18.37
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
Abstract
Heymach, John V
The University of Texas M. D. Anderson Cancer Center
11/30/2009
18.37
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer.
Abstract
Choueiri, Toni K
Stanford University School of Medicine
10/13/2009
18.37
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
03/30/2009
18.37
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice.
Abstract
Alitalo, Kari
University of Helsinki
01/29/2013
14.73
Circulation
Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis.
Abstract
Hong, Young-Kwon
University of Southern California
01/24/2012
14.73
Circulation
9-cis retinoic acid promotes lymphangiogenesis and enhances lymphatic vessel regeneration: therapeutic implications of 9-cis retinoic acid for secondary lymphedema.
Abstract
Ruhrberg, Christiana
University College London
06/10/2011
14.73
Neuron
VEGF signaling through neuropilin 1 guides commissural axon crossing at the optic chiasm.
Abstract
Carmeliet, Peter
University of Leuven
06/10/2011
14.73
Neuron
VEGF mediates commissural axon chemoattraction through its receptor Flk1.
Abstract
Alitalo, Kari
University of Helsinki
10/11/2010
14.73
Circulation
Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation.
Abstract
Yoon, Young-sup
Emory University School of Medicine
09/20/2010
14.73
Circulation
Podoplanin-expressing cells derived from bone marrow play a crucial role in postnatal lymphatic neovascularization.
Abstract
Lemström, Karl B
FI-00014 University of Helsinki and Helsinki University Central Hospital
03/15/2010
14.73
Circulation
Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
03/23/2009
14.73
Circulation
Collagen-targeting vascular endothelial growth factor improves cardiac performance after myocardial infarction.
Abstract
Simons, Michael
Yale University School of Medicine
05/03/2013
14.03
Developmental cell
The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis.
Abstract
Petrova, Tatiana V
University of Helsinki
02/02/2012
14.03
Developmental cell
Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation.
Abstract
Simons, Michael
Yale University School of Medicine
05/06/2010
14.03
Developmental cell
VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis.
Abstract
Kiefer, Friedemann
Max Planck Institute for Molecular Biomedicine
03/16/2010
14.03
Developmental cell
Regulation of developmental lymphangiogenesis by Syk(+) leukocytes.
Abstract
Lammert, Eckhard
Heinrich-Heine-University of Düsseldorf
10/26/2009
14.03
Developmental cell
The molecular basis of vascular lumen formation in the developing mouse aorta.
Abstract
Johnson, Randall S
University of California
06/17/2009
14.03
Developmental cell
You don't need a PHD to grow a tumor.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
09/13/2010
13.85
The Journal of experimental medicine
Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
05/13/2013
13.75
Journal of the National Cancer Institute
Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions.
Abstract
Alitalo, Kari
University of Helsinki
02/17/2012
13.75
Journal of the National Cancer Institute
Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.
Abstract
Carmeliet, Peter
University of Leuven
12/12/2013
13.66
Cell metabolism
Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.
Abstract
Carmeliet, Peter
University of Leuven
08/22/2013
13.66
Cell metabolism
Role of endothelial cell metabolism in vessel sprouting.
Abstract
Mooney, David J
Harvard University
12/30/2010
13.19
Nano letters
Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis.
Abstract
Kahn, Mark L
University of Pennsylvania
02/12/2014
13.06
The Journal of clinical investigation
Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life.
Abstract
Carmeliet, Peter
University of Leuven
08/01/2013
13.06
The Journal of clinical investigation
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.
Abstract
Simons, Michael
Yale University School of Medicine
02/08/2013
13.06
The Journal of clinical investigation
Endothelial ERK signaling controls lymphatic fate specification.
Abstract
Kahn, Mark L
University of Pennsylvania
05/24/2012
13.06
The Journal of clinical investigation
Blood flow reprograms lymphatic vessels to blood vessels.
Abstract
Simons, Michael
Yale University School of Medicine
07/11/2011
13.06
The Journal of clinical investigation
FGF-dependent regulation of VEGF receptor 2 expression in mice.
Abstract
Alitalo, Kari
University of Helsinki
05/23/2011
13.06
The Journal of clinical investigation
The yin, the yang, and the angiopoietin-1.
Abstract
Heymach, John V
The University of Texas M. D. Anderson Cancer Center
03/23/2011
13.06
The Journal of clinical investigation
Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma.
Abstract
McDonald, Donald M
University of California-San Francisco
09/14/2009
13.06
The Journal of clinical investigation
TNF-alpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice.
Abstract
Simons, Michael
Yale University School of Medicine
02/25/2012
12.89
Current opinion in cell biology
VEGF signaling inside vascular endothelial cells and beyond.
Abstract
Adams, Ralf H
Cancer Research UK London Research Institute
10/04/2010
12.89
Current opinion in cell biology
Dynamics of endothelial cell behavior in sprouting angiogenesis.
Abstract
Lammert, Eckhard
Heinrich-Heine-University
08/02/2010
12.89
Current opinion in cell biology
Resolving cell-cell junctions: lumen formation in blood vessels.
Abstract
Alitalo, Kari
University of Helsinki
02/21/2009
12.89
Current opinion in cell biology
VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
Abstract
Ellis, Lee M
The University of Texas MD Anderson Cancer Center
02/14/2012
11.96
Nature reviews. Clinical oncology
Antiangiogenic therapy--evolving view based on clinical trial results.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
03/08/2011
11.96
Nature reviews. Clinical oncology
HCC and angiogenesis: possible targets and future directions.
Abstract
Oliver, Guillermo
Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105
10/20/2011
11.65
Genes & development
Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves.
Abstract
Oliver, Guillermo
Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105
10/04/2010
11.65
Genes & development
Current views on the function of the lymphatic vasculature in health and disease.
Abstract
Alitalo, Kari
University of Helsinki
05/04/2010
11.65
Genes & development
Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development.
Abstract
Oliver, Guillermo
Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105
04/02/2010
11.65
Genes & development
The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
11/25/2009
10.92
Trends in pharmacological sciences
Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
12/07/2010
10.47
European heart journal
Capillary enlargement, not sprouting angiogenesis, determines beneficial therapeutic effects and side effects of angiogenic gene therapy.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
05/12/2012
10.40
Trends in immunology
Regulation and implications of inflammatory lymphangiogenesis.
Abstract
Alitalo, Kari
University of Helsinki
04/12/2011
10.35
Trends in molecular medicine
VEGF and angiopoietin signaling in tumor angiogenesis and metastasis.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
08/02/2013
10.33
EMBO molecular medicine
VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy.
Abstract
Mercurio, Arthur M
University of Massachusetts Medical School
02/21/2013
10.33
EMBO molecular medicine
GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation.
Abstract
Hodivala-Dilke, Kairbaan M
Queen Mary University of London
12/14/2010
10.33
EMBO molecular medicine
Endothelial FAK is required for tumour angiogenesis.
Abstract
Petrova, Tatiana V
University of Helsinki
05/17/2011
10.26
The Journal of cell biology
Lymphatic vascular morphogenesis in development, physiology, and disease.
Abstract
Petrova, Tatiana V
University of Helsinki
04/27/2009
10.26
The Journal of cell biology
FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1.
Abstract
Lammert, Eckhard
Heinrich-Heine University
10/11/2012
9.92
Nature protocols
Pharmacological manipulation of blood and lymphatic vascularization in ex vivo-cultured mouse embryos.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
03/22/2012
9.92
Nature protocols
An isolated tumor perfusion model in mice.
Abstract
Cao, Yihai
Karolinska Institute
05/19/2011
9.92
Nature protocols
Mouse corneal lymphangiogenesis model.
Abstract
Cao, Yihai
Karolinska Institute
11/04/2010
9.92
Nature protocols
Hypoxia-induced metastasis model in embryonic zebrafish.
Abstract
Ruhrberg, Christiana
University College London
01/11/2013
9.90
Blood
NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
08/14/2012
9.90
Blood
ROCK suppression promotes differentiation and expansion of endothelial cells from embryonic stem cell-derived Flk1(+) mesodermal precursor cells.
Abstract
Oliver, Guillermo
Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105
08/02/2012
9.90
Blood
Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
06/16/2011
9.90
Blood
Angiopoietin-1 promotes endothelial differentiation from embryonic stem cells and induced pluripotent stem cells.
Abstract
Alitalo, Kari
University of Helsinki
05/12/2011
9.90
Blood
Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.
Abstract
Luo, Yongzhang
Tsinghua University
04/11/2011
9.90
Blood
Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
03/01/2011
9.90
Blood
An important role of lymphatic vessel activation in limiting acute inflammation.
Abstract
Alitalo, Kari
University of Helsinki
12/08/2010
9.90
Blood
Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.
Abstract
Hong, Young-Kwon
University of Southern California
10/20/2010
9.90
Blood
Visualization of lymphatic vessels by Prox1-promoter directed GFP reporter in a bacterial artificial chromosome-based transgenic mouse.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
08/17/2010
9.90
Blood
Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin.
Abstract
Bautch, Victoria L
The University of North Carolina at Chapel Hill
07/27/2010
9.90
Blood
Angiogenic factor signaling regulates centrosome duplication in endothelial cells of developing blood vessels.
Abstract
Carmeliet, Peter
Vesalius Research Center, Vlaams Iustituut voor Biotechnologie, Katholieke Universiteit Leuven, Campus Gasthuisberg, Herestraat 49, Leuven
07/14/2010
9.90
Blood
Role of synectin in lymphatic development in zebrafish and frogs.
Abstract
Ruhrberg, Christiana
University College London
04/19/2010
9.90
Blood
Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction.
Abstract
Kahn, Mark L
University of Pennsylvania
04/02/2010
9.90
Blood
Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling.
Abstract
Petrova, Tatiana V
Molecular and Cancer Biology Program, Biomedicum Helsinki, Helsinki
11/30/2009
9.90
Blood
Liprin (beta)1 is highly expressed in lymphatic vasculature and is important for lymphatic vessel integrity.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
04/03/2009
9.90
Blood
Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
12/19/2008
9.90
Blood
Toll-like receptor 4 in lymphatic endothelial cells contributes to LPS-induced lymphangiogenesis by chemotactic recruitment of macrophages.
Abstract
Cao, Yihai
Karolinska Institute
08/05/2013
9.81
Proceedings of the National Academy of Sciences of the United States of America
Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.
Abstract
Alitalo, Kari
University of Helsinki
07/22/2013
9.81
Proceedings of the National Academy of Sciences of the United States of America
Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation.
Abstract
Cao, Yihai
Karolinska Institute
07/01/2013
9.81
Proceedings of the National Academy of Sciences of the United States of America
Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
03/25/2013
9.81
Proceedings of the National Academy of Sciences of the United States of America
Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment.
Abstract
Cao, Yihai
Karolinska Institute
12/24/2012
9.81
Proceedings of the National Academy of Sciences of the United States of America
Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs.
Abstract
Cao, Yihai
Karolinska Institute
09/11/2012
9.81
Proceedings of the National Academy of Sciences of the United States of America
Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis.
Abstract
Carmeliet, Peter
University of Leuven
07/29/2011
9.81
Proceedings of the National Academy of Sciences of the United States of America
VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
12/20/2010
9.81
Proceedings of the National Academy of Sciences of the United States of America
C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells.
Abstract
Alitalo, Kari
University of Helsinki
02/10/2010
9.81
Proceedings of the National Academy of Sciences of the United States of America
Structural determinants of growth factor binding and specificity by VEGF receptor 2.
Abstract
Johnson, Randall S
University of California
02/08/2010
9.81
Proceedings of the National Academy of Sciences of the United States of America
Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis.
Abstract
Cao, Yihai
Karolinska Institute
12/22/2009
9.81
Proceedings of the National Academy of Sciences of the United States of America
VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.
Abstract
Cao, Yihai
Karolinska Institute
11/03/2009
9.81
Proceedings of the National Academy of Sciences of the United States of America
Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
10/19/2009
9.81
Proceedings of the National Academy of Sciences of the United States of America
An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris.
Abstract
Cao, Yihai
Karolinska Institutet
10/12/2009
9.81
Proceedings of the National Academy of Sciences of the United States of America
Nitric oxide permits hypoxia-induced lymphatic perfusion by controlling arterial-lymphatic conduits in zebrafish and glass catfish.
Abstract
Cao, Yihai
Karolinska Institute
09/25/2009
9.81
Proceedings of the National Academy of Sciences of the United States of America
Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
04/03/2009
9.81
Proceedings of the National Academy of Sciences of the United States of America
G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.
Abstract
Mooney, David J
Harvard University
01/06/2009
9.81
Proceedings of the National Academy of Sciences of the United States of America
Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
06/20/2012
9.49
Circulation research
An unexpected role of semaphorin3a-neuropilin-1 signaling in lymphatic vessel maturation and valve formation.
Abstract
Alitalo, Kari
University of Helsinki
05/14/2009
9.49
Circulation research
Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.
Abstract
Alitalo, Kari
University of Helsinki
09/01/2013
9.40
Cold Spring Harbor perspectives in biology
Receptor tyrosine kinase-mediated angiogenesis.
Abstract
Kiefer, Friedemann
Max Planck Institute for Molecular Biomedicine
01/08/2013
9.21
The EMBO journal
A novel multistep mechanism for initial lymphangiogenesis in mouse embryos based on ultramicroscopy.
Abstract
Lammert, Eckhard
Heinrich-Heine University
12/13/2011
9.21
The EMBO journal
Mechanoinduction of lymph vessel expansion.
Abstract
Hong, Young-Kwon
University of Southern California
08/12/2010
9.13
PLoS pathogens
Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi's sarcoma herpes virus.
Abstract
Carmeliet, Peter
University of Leuven
09/27/2013
8.56
Pharmacology & therapeutics
Bevacizumab and micrometastases: revisiting the preclinical and clinical rollercoaster.
Abstract
Choueiri, Toni K
Stanford University School of Medicine
02/01/2011
8.49
European urology
Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal cell carcinoma.
Abstract
Carmeliet, Peter
University of Leuven
11/22/2010
8.09
Current opinion in genetics & development
Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
Abstract
Simons, Michael
Yale University School of Medicine
08/09/2012
7.95
Physiology (Bethesda, Md.)
An inside view: VEGF receptor trafficking and signaling.
Abstract
Bautch, Victoria L
The University of North Carolina at Chapel Hill
10/20/2011
7.95
Physiology (Bethesda, Md.)
Ups and downs of guided vessel sprouting: the role of polarity.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
05/21/2013
7.86
Cancer research
VEGF-C and VEGF-D blockade inhibits inflammatory skin carcinogenesis.
Abstract
McDonald, Donald M
University of California
04/10/2013
7.86
Cancer research
Inhibition of c-Met reduces lymphatic metastasis in RIP-Tag2 transgenic mice.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
02/25/2013
7.86
Cancer research
Vascular normalization as an emerging strategy to enhance cancer immunotherapy.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
12/14/2012
7.86
Cancer research
Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.
Abstract
Alitalo, Kari
University of Helsinki
05/16/2012
7.86
Cancer research
Deletion of the endothelial Bmx tyrosine kinase decreases tumor angiogenesis and growth.
Abstract
Johnson, Randall S
University of California
05/03/2012
7.86
Cancer research
Loss of fibroblast HIF-1α accelerates tumorigenesis.
Abstract
Dvorak, Harold F
Beth Israel Deaconess Medical Center and Harvard Medical School
04/17/2012
7.86
Cancer research
Anti-VEGF/VEGFR therapy for cancer: reassessing the target.
Abstract
Dvorak, Harold F
Beth Israel Deaconess Medical Center and Harvard Medical School
09/21/2011
7.86
Cancer research
Tumor-surrogate blood vessel subtypes exhibit differential susceptibility to anti-VEGF therapy.
Abstract
Stacker, Steven A
Royal Melbourne Hospital
08/25/2011
7.86
Cancer research
A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth.
Abstract
Sood, Anil K
University of Texas M.D. Anderson Cancer Center
07/27/2011
7.86
Cancer research
Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
Abstract
McDonald, Donald M
University of California
03/02/2011
7.86
Cancer research
Reduced VEGF production, angiogenesis, and vascular regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
01/04/2011
7.86
Cancer research
Glioblastoma recurrence after cediranib therapy in patients: lack of "rebound" revascularization as mode of escape.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
11/30/2010
7.86
Cancer research
Increase of plasma VEGF after intravenous administration of bevacizumab is predicted by a pharmacokinetic model.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
10/26/2010
7.86
Cancer research
In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
09/07/2010
7.86
Cancer research
Quantitative imaging of lymphatic function with liposomal indocyanine green.
Abstract
McDonald, Donald M
University of California
03/02/2010
7.86
Cancer research
Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth.
Abstract
Liu, Mingyao
East China Normal University
02/16/2010
7.86
Cancer research
Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
10/13/2009
7.86
Cancer research
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.
Abstract
Liu, Mingyao
East China Normal University
08/11/2009
7.86
Cancer research
Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation.
Abstract
Liu, Mingyao
East China Normal University
06/30/2009
7.86
Cancer research
Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Abstract
Dvorak, Harold F
Beth Israel Deaconess Medical Center and Harvard Medical School
05/12/2009
7.86
Cancer research
VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation.
Abstract
McDonald, Donald M
University of California
04/28/2009
7.86
Cancer research
Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors.
Abstract
Dvorak, Harold F
Beth Israel Deaconess Medical Center and Harvard Medical School
04/07/2009
7.86
Cancer research
The L6 protein TM4SF1 is critical for endothelial cell function and tumor angiogenesis.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
12/11/2009
7.81
Cytokine & growth factor reviews
Pathways mediating VEGF-independent tumor angiogenesis.
Abstract
Alitalo, Kari
University of Helsinki
02/10/2011
7.80
Science translational medicine
Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis.
Abstract
Ellis, Lee M
The University of Texas MD Anderson Cancer Center
04/02/2013
7.74
Clinical cancer research : an official journal of the American Association for Cancer Research
Predictive biomarkers for bevacizumab: are we there yet?
Abstract
Luo, Yongzhang
Tsinghua University
08/29/2012
7.74
Clinical cancer research : an official journal of the American Association for Cancer Research
The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
Abstract
Heymach, John V
The University of Texas M. D. Anderson Cancer Center
06/01/2011
7.74
Clinical cancer research : an official journal of the American Association for Cancer Research
Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept.
Abstract
Ellis, Lee M
The University of Texas MD Anderson Cancer Center
11/03/2009
7.74
Clinical cancer research : an official journal of the American Association for Cancer Research
Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
Abstract
Carmeliet, Peter
University of Leuven
05/26/2009
7.74
Clinical cancer research : an official journal of the American Association for Cancer Research
"Antimyeloangiogenic" therapy for cancer by inhibiting PlGF.
Abstract
Heymach, John V
The University of Texas M. D. Anderson Cancer Center
05/15/2009
7.74
Clinical cancer research : an official journal of the American Association for Cancer Research
Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non-small cell lung cancer.
Abstract
Alitalo, Kari
University of Helsinki
07/02/2013
7.50
Science signaling
The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
04/16/2013
7.50
Science signaling
Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases.
Abstract
Cao, Yihai
Karolinska Institute
02/24/2009
7.50
Science signaling
Positive and negative modulation of angiogenesis by VEGFR1 ligands.
Abstract
Zhang, Yuanyuan
Wake Forest School of Medicine
08/09/2013
7.40
Biomaterials
The effect of urine-derived stem cells expressing VEGF loaded in collagen hydrogels on myogenesis and innervation following after subcutaneous implantation in nude mice.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
04/06/2013
7.40
Biomaterials
Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis.
Abstract
Chen, Xiaoyuan
Stanford University School of Medicine
05/03/2012
7.40
Biomaterials
Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
11/24/2010
7.40
Biomaterials
Regeneration of full-thickness abdominal wall defects in rats using collagen scaffolds loaded with collagen-binding basic fibroblast growth factor.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
10/18/2010
7.40
Biomaterials
The promotion of neural regeneration in an extreme rat spinal cord injury model using a collagen scaffold containing a collagen binding neuroprotective protein and an EGFR neutralizing antibody.
Abstract
Mooney, David J
Harvard University
08/25/2010
7.40
Biomaterials
Modulating Notch signaling to enhance neovascularization and reperfusion in diabetic mice.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
08/15/2010
7.40
Biomaterials
The promotion of neurological recovery in the rat spinal cord crushed injury model by collagen-binding BDNF.
Abstract
Mooney, David J
Harvard University
11/10/2009
7.40
Biomaterials
Effects of VEGF temporal and spatial presentation on angiogenesis.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
07/01/2009
7.40
Biomaterials
The effect of collagen-binding NGF-beta on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model.
Abstract
Mooney, David J
Harvard University
05/29/2009
7.40
Biomaterials
Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling.
Abstract
Zhang, Yun
Shandong University
04/03/2008
7.08
International journal of cardiology
Lymphangiogenesis promotes inflammation and neointimal hyperplasia after adventitia removal in the rat carotid artery.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
10/23/2012
6.87
Molecular therapy : the journal of the American Society of Gene Therapy
AAV9-mediated VEGF-B gene transfer improves systolic function in progressive left ventricular hypertrophy.
Abstract
Ruhrberg, Christiana
University College London
01/11/2013
6.65
Seminars in cell & developmental biology
Neuropilin signalling in vessels, neurons and tumours.
Abstract
Ruhrberg, Christiana
University College London
03/21/2012
6.60
Development (Cambridge, England)
Diverse roles for VEGF-A in the nervous system.
Abstract
Ruhrberg, Christiana
University College London
08/18/2011
6.60
Development (Cambridge, England)
The cytoplasmic domain of neuropilin 1 is dispensable for angiogenesis, but promotes the spatial separation of retinal arteries and veins.
Abstract
Ruhrberg, Christiana
University College London
08/10/2011
6.60
Development (Cambridge, England)
VEGF signalling controls GnRH neuron survival via NRP1 independently of KDR and blood vessels.
Abstract
Mercurio, Arthur M
University of Massachusetts Medical School
06/22/2011
6.60
Development (Cambridge, England)
Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland.
Abstract
Hodivala-Dilke, Kairbaan M
Bart's & The London Queen Mary's School of Medicine & Dentistry
11/12/2009
6.60
Development (Cambridge, England)
Regulation of lymphatic-blood vessel separation by endothelial Rac1.
Abstract
Bautch, Victoria L
The University of North Carolina at Chapel Hill
01/28/2009
6.60
Development (Cambridge, England)
Neurovascular development uses VEGF-A signaling to regulate blood vessel ingression into the neural tube.
Abstract
Lammert, Eckhard
Heinrich-Heine University
05/12/2013
6.57
Cellular and molecular life sciences : CMLS
Mechanical forces in lymphatic vascular development and disease.
Abstract
Bautch, Victoria L
The University of North Carolina at Chapel Hill
03/12/2013
6.57
Cellular and molecular life sciences : CMLS
Neurovascular development and links to disease.
Abstract
Wang, Yingqun
Zhongda Hospital Affiliated to Southeast University
01/26/2010
6.57
Cellular and molecular life sciences : CMLS
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease.
Abstract
Choueiri, T K
University of Calgary
11/05/2011
6.43
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy.
Abstract
Choueiri, T K
University of Calgary
11/29/2010
6.43
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes.
Abstract
Zhang, Y
Institutes of Medical Sciences
07/15/2013
6.37
Oncogene
Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma.
Abstract
Detmar, M
Swiss Federal Institute of Technology
12/19/2011
6.37
Oncogene
Interaction of tumor cells and lymphatic vessels in cancer progression.
Abstract
Ellis, L M
The University of Texas MD Anderson Cancer Center
11/08/2010
6.37
Oncogene
Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells.
Abstract
Heymach, J V
The University of Texas MD Anderson Cancer Center
03/08/2010
6.37
Oncogene
Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
Abstract
Bautch, Victoria L
The University of North Carolina at Chapel Hill
06/06/2013
6.37
Arteriosclerosis, thrombosis, and vascular biology
Flt-1 (vascular endothelial growth factor receptor-1) is essential for the vascular endothelial growth factor-Notch feedback loop during angiogenesis.
Abstract
Kahn, Mark L
University of Pennsylvania
11/11/2010
6.37
Arteriosclerosis, thrombosis, and vascular biology
Platelets: covert regulators of lymphatic development.
Abstract
Alitalo, Kari
University of Helsinki
11/12/2009
6.37
Arteriosclerosis, thrombosis, and vascular biology
Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
05/21/2009
6.37
Arteriosclerosis, thrombosis, and vascular biology
Inhibition of VEGF or TGF-{beta} signaling activates endothelium and increases leukocyte rolling.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
01/22/2009
6.37
Arteriosclerosis, thrombosis, and vascular biology
Vascular endothelial growth factor.
Abstract
Carmeliet, P
Vesalius Research Center, KU Leuven, Leuven
04/15/2008
6.37
Journal of medical genetics
Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
07/03/2012
6.32
The Journal of pathology
Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors.
Abstract
Luo, Yongzhang
Tsinghua University
09/27/2010
6.32
The Journal of pathology
Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
11/13/2008
6.31
The Journal of investigative dermatology
Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
03/07/2012
6.11
Journal of cell science
Role of shear-stress-induced VEGF expression in endothelial cell survival.
Abstract
Mercurio, Arthur M
University of Massachusetts Medical School
02/02/2012
6.11
Journal of cell science
Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
06/10/2013
6.06
Cardiovascular research
The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
04/14/2011
6.06
Cardiovascular research
Epigenetic regulation of key vascular genes and growth factors.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
12/02/2009
6.06
Cardiovascular research
The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.
Abstract
Carmeliet, Peter
University of Leuven
12/01/2009
6.06
Cardiovascular research
Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
11/09/2013
6.06
Angiogenesis
Lymphatic vessels: new targets for the treatment of inflammatory diseases.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
01/17/2013
6.06
Angiogenesis
Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
09/09/2012
6.06
Angiogenesis
Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformations.
Abstract
Luo, Yongzhang
Tsinghua University
06/19/2012
6.06
Angiogenesis
The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells.
Abstract
Adams, Ralf H
University of Münster
02/12/2009
6.06
Angiogenesis
Molecular differentiation and specialization of vascular beds.
Abstract
Ribatti, Domenico
University of Bari Medical School
03/23/2011
6.05
Cancer treatment reviews
Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
02/26/2013
5.95
Neoplasia (New York, N.Y.)
Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.
Abstract
Chen, Xiaoyuan
Stanford University School of Medicine
07/12/2013
5.91
Nanoscale
VEGF-loaded graphene oxide as theranostics for multi-modality imaging-monitored targeting therapeutic angiogenesis of ischemic muscle.
Abstract
Chen, Xiaoyuan
Stanford University School of Medicine
08/01/2011
5.83
Chemistry & biology
Size effect in molecular imaging of vascular endothelial growth factor.
Abstract
Luo, Yongzhang
Tsinghua University
01/22/2010
5.79
Journal of immunology (Baltimore, Md. : 1950)
NFAT1 mediates placental growth factor-induced myelomonocytic cell recruitment via the induction of TNF-alpha.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
05/09/2013
5.73
Journal of controlled release : official journal of the Controlled Release Society
Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery.
Abstract
Carmeliet, P
Vesalius Research Center, KU Leuven, Leuven
10/25/2008
5.73
Journal of thrombosis and haemostasis : JTH
Development of targeted angiogenic medicine.
Abstract
Chen, Xiaoyuan
Stanford University School of Medicine
10/23/2008
5.73
Stroke; a journal of cerebral circulation
Positron emission tomography imaging of poststroke angiogenesis.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
05/16/2013
5.71
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Vascular endothelial growth factor is important for brown adipose tissue development and maintenance.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
11/08/2011
5.71
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Heat treatment of retinal pigment epithelium induces production of elastic lamina components and antiangiogenic activity.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
04/16/2010
5.71
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis.
Abstract
Liu, Mingyao
East China Normal University
03/22/2011
5.70
Carcinogenesis
1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.
Abstract
Liu, Mingyao
East China Normal University
08/23/2010
5.70
Carcinogenesis
Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.
Abstract
Zhang, Yafang
Mudanjiang Medical University
06/15/2011
5.54
European journal of cancer (Oxford, England : 1990)
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Abstract
Motzer, Robert J
Pfizer Oncology, 10646 Science Center Drive, La Jolla, San Diego, CA, 92121
04/08/2011
5.54
European journal of cancer (Oxford, England : 1990)
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma.
Abstract
Ribatti, Domenico
University of Bari Medical School
05/04/2009
5.54
European journal of cancer (Oxford, England : 1990)
Angiogenesis in pre-malignant conditions.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
05/17/2010
5.53
Molecular and cellular biology
miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
09/29/2012
5.45
Ophthalmology
Vascular endothelial growth factor a in intraocular vascular disease.
Abstract
Sood, Anil K
University of Texas M.D. Anderson Cancer Center
12/24/2008
5.44
International journal of cancer. Journal international du cancer
Functional significance of VEGFR-2 on ovarian cancer cells.
Abstract
Wang, Yaohe
Queen Mary University of London
12/26/2012
5.40
Journal of virology
Vascular endothelial growth factor A promotes vaccinia virus entry into host cells via activation of the Akt pathway.
Abstract
Cao, Yihai
Karolinska Institute
01/16/2013
5.36
Cell cycle (Georgetown, Tex.)
Clock controls angiogenesis.
Abstract
Cao, Yihai
Karolinska Institute
05/15/2010
5.36
Cell cycle (Georgetown, Tex.)
Cancer-associated retinopathy: a new mechanistic insight on vascular remodeling.
Abstract
Cao, Yihai
Karolinska Institute
03/06/2010
5.36
Cell cycle (Georgetown, Tex.)
Pathological angiogenesis facilitates tumor cell dissemination and metastasis.
Abstract
Ribatti, Domenico
University of Bari Medical School
12/28/2012
5.27
Critical reviews in oncology/hematology
Anti-angiogenesis in neuroblastoma.
Abstract
Liu, Mingyao
East China Normal University
12/27/2011
5.23
Molecular cancer therapeutics
Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
Abstract
Liu, Mingyao
East China Normal University
03/03/2011
5.23
Molecular cancer therapeutics
(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
12/24/2009
5.22
PLoS computational biology
The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
05/01/2012
5.09
The AAPS journal
Predicting the effects of anti-angiogenic agents targeting specific VEGF isoforms.
Abstract
Ellis, L M
The University of Texas MD Anderson Cancer Center
03/15/2011
5.04
British journal of cancer
Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration.
Abstract
Dvorak, H F
Beth Israel Deaconess Medical Center and Harvard Medical School
02/24/2009
5.04
British journal of cancer
Why are tumour blood vessels abnormal and why is it important to know?
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
02/26/2010
4.94
Molecular biology of the cell
Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action.
Abstract
Hodivala-Dilke, Kairbaan M
Queen Mary University of London
11/01/2012
4.94
Disease models & mechanisms
Endogenous ribosomal protein L29 (RPL29): a newly identified regulator of angiogenesis in mice.
Abstract
McDonald, Donald M
University of California
02/04/2013
4.89
The American journal of pathology
Transgenic overexpression of interleukin-1β induces persistent lymphangiogenesis but not angiogenesis in mouse airways.
Abstract
Lemström, Karl B
FI-00014 University of Helsinki and Helsinki University Central Hospital
09/07/2012
4.89
The American journal of pathology
Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
06/29/2012
4.89
The American journal of pathology
A brief history of anti-VEGF for the treatment of ocular angiogenesis.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
12/23/2011
4.89
The American journal of pathology
Inflammation-induced lymph node lymphangiogenesis is reversible.
Abstract
McDonald, Donald M
University of California
10/15/2010
4.89
The American journal of pathology
Angiopoietin-2-driven vascular remodeling in airway inflammation.
Abstract
Hodivala-Dilke, Kairbaan M
Queen Mary University of London
07/16/2010
4.89
The American journal of pathology
Endothelial alpha3beta1-integrin represses pathological angiogenesis and sustains endothelial-VEGF.
Abstract
McDonald, Donald M
University of California
02/25/2010
4.89
The American journal of pathology
Ricinus communis agglutinin I leads to rapid down-regulation of VEGFR-2 and endothelial cell apoptosis in tumor blood vessels.
Abstract
Liu, Mingyao
East China Normal University
02/18/2010
4.89
The American journal of pathology
Functions of type II pneumocyte-derived vascular endothelial growth factor in alveolar structure, acute inflammation, and vascular permeability.
Abstract
McDonald, Donald M
University of California
02/04/2010
4.89
The American journal of pathology
Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation.
Abstract
McDonald, Donald M
University of California-San Francisco
01/21/2010
4.89
The American journal of pathology
Steroid-resistant lymphatic remodeling in chronically inflamed mouse airways.
Abstract
McDonald, Donald M
University of California
10/08/2009
4.89
The American journal of pathology
Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
09/17/2009
4.89
The American journal of pathology
Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm.
Abstract
Dvorak, Harold F
Beth Israel Deaconess Medical Center and Harvard Medical School
09/03/2009
4.89
The American journal of pathology
Vascular permeability and pathological angiogenesis in caveolin-1-null mice.
Abstract
McDonald, Donald M
University of California-San Francisco
05/14/2009
4.89
The American journal of pathology
alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
10/25/2010
4.87
Acta biomaterialia
Improved cellularization and angiogenesis using collagen scaffolds chemically conjugated with vascular endothelial growth factor.
Abstract
Ribatti, D
11 Policlinico
03/23/2010
4.86
Current medicinal chemistry
Targeting tumor lymphangiogenesis: an update.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
07/22/2013
4.86
Inflammatory bowel diseases
Blockade of VEGF receptor-3 aggravates inflammatory bowel disease and lymphatic vessel enlargement.
Abstract
Johnson, Randall S
University of California
06/14/2010
4.82
Glia
Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina.
Abstract
Johnson, Randall S
University of California
12/30/2013
4.78
Oncotarget
Endothelial hypoxic metabolism in carcinogenesis and dissemination: HIF-A isoforms are a NO metastatic phenomenon.
Abstract
Stacker, Steven A
Royal Melbourne Hospital
08/19/2012
4.78
Oncotarget
The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.
Abstract
Chen, Xiaoyuan
Stanford University School of Medicine
02/02/2009
4.78
Molecular pharmaceutics
Site-specifically biotinylated VEGF(121) for near-infrared fluorescence imaging of tumor angiogenesis.
Abstract
Simons, Michael
Yale University School of Medicine
11/14/2013
4.77
The Journal of biological chemistry
Angiopoietin-2 secretion by endothelial cell exosomes: regulation by the phosphatidylinositol 3-kinase (PI3K)/Akt/endothelial nitric oxide synthase (eNOS) and syndecan-4/syntenin pathways.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
02/23/2011
4.77
The Journal of biological chemistry
Double anti-angiogenic and anti-inflammatory protein Valpha targeting VEGF-A and TNF-alpha in retinopathy and psoriasis.
Abstract
Hodivala-Dilke, Kairbaan M
Queen Mary University of London
10/16/2009
4.77
The Journal of biological chemistry
Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
04/14/2009
4.77
The Journal of biological chemistry
Novel vascular endothelial growth factor D variants with increased biological activity.
Abstract
Heymach, John V
The University of Texas M. D. Anderson Cancer Center
05/04/2009
4.77
Cancer
Circulating biomarkers for vascular endothelial growth factor inhibitors in renal cell carcinoma.
Abstract
Zhang, Yun
Shandong University
02/16/2011
4.67
Journal of molecular medicine (Berlin, Germany)
Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction.
Abstract
Dvorak, Harold F
Harvard Medical School
05/20/2010
4.52
Seminars in thrombosis and hemostasis
Heterogeneity of the tumor vasculature.
Abstract
Hong, Young-Kwon
University of Southern California
05/20/2010
4.52
Seminars in thrombosis and hemostasis
Heterogeneity and plasticity of lymphatic endothelial cells.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
04/15/2010
4.52
Current opinion in hematology
Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis.
Abstract
Alitalo, Kari
University of Helsinki
04/15/2010
4.52
Current opinion in hematology
How do angiopoietins Tie in with vascular endothelial growth factors?
Abstract
Chen, Xi
Chinese Academy of Medical Sciences and Peking Union Medical College
09/11/2009
4.46
Stem cells and development
Lysophosphatidic acid protects mesenchymal stem cells against ischemia-induced apoptosis in vivo.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
04/24/2013
4.43
Breast cancer research and treatment
Dynamics of lymphatic regeneration and flow patterns after lymph node dissection.
Abstract
Ambati, Jayakrishna
Departments of Ophthalmology & Visual Sciences, Lexington, Kentucky
10/21/2010
4.31
Annals of the New York Academy of Sciences
Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.
Abstract
Sood, Anil K
University of Texas M.D. Anderson Cancer Center
07/07/2012
4.24
Cancer letters
Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma.
Abstract
Ribatti, Domenico
University of Bari Medical School
03/22/2011
4.24
Cancer letters
The controversial role of placental growth factor in tumor growth.
Abstract
Hong, Yong-Kil
The Catholic University of Korea
08/06/2009
4.24
Cancer letters
Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Abstract
Wang, Yizheng
Second Military Medical University
04/24/2009
4.24
Cancer letters
Critical role of TRPC6 channels in VEGF-mediated angiogenesis.
Abstract
Ribatti, Domenico
University of Bari Medical School
01/17/2009
4.24
Cancer letters
An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.
Abstract
Wang, Yi
Third Military Medical University
10/17/2009
4.22
American journal of ophthalmology
Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
12/16/2009
4.22
Human gene therapy
Intravitreal adenoviral 15-lipoxygenase-1 gene transfer prevents vascular endothelial growth factor A-induced neovascularization in rabbit eyes.
Abstract
Zhang, Ying
USA; Laboratory for Conservation and Utilization of Bio-resources Yunnan University
05/16/2013
4.19
Molecular and cellular endocrinology
Decursin inhibited proliferation and angiogenesis of endothelial cells to suppress diabetic retinopathy via VEGFR2.
Abstract
Zhang, Yanmin
Xi'an Jiaotong University
08/02/2013
4.13
Journal of cellular and molecular medicine
Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
10/16/2009
4.13
Journal of cellular and molecular medicine
A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
07/06/2009
4.13
Journal of cellular and molecular medicine
Lymphangiogenesis and cancer metastasis.
Abstract
Chen, Xiangmei
PLA General Hospital and Military Medical Postgraduate College
05/08/2013
4.09
PloS one
Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
11/08/2011
4.09
PloS one
A two-compartment model of VEGF distribution in the mouse.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
09/13/2011
4.09
PloS one
Analysis of VEGF--a regulated gene expression in endothelial cells to identify genes linked to angiogenesis.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
08/02/2010
4.09
PloS one
Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
07/29/2010
4.09
PloS one
Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model.
Abstract
Hodivala-Dilke, Kairbaan M
Queen Mary University of London
03/22/2010
4.09
PloS one
Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
09/18/2009
4.09
PloS one
VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
04/08/2009
4.09
PloS one
PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
04/08/2009
4.09
PloS one
A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
03/31/2009
4.09
PloS one
Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells.
Abstract
Ruhrberg, Christiana
University College London
07/10/2012
4.07
Developmental biology
NRP1 and NRP2 cooperate to regulate gangliogenesis, axon guidance and target innervation in the sympathetic nervous system.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
07/26/2011
4.07
Developmental biology
Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development.
Abstract
Wang, Yan
The General Hospital of Chinese People's Liberation Army
06/02/2010
4.05
Clinical immunology (Orlando, Fla.)
Analysis of JAK2 and STAT3 polymorphisms in patients with ankylosing spondylitis in Chinese Han population.
Abstract
Wang, Yan
The General Hospital of Chinese People's Liberation Army
08/01/2013
4.02
Bone
Effects of endostar combined multidrug chemotherapy in osteosarcoma.
Abstract
Koh, Gou Young
Korea Advanced Institute of Science and Technology
04/11/2011
3.99
Molecular cancer
Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
Abstract
Jain, Rakesh K
Massachusetts General Hospital and Harvard Medical School
05/18/2010
3.91
The oncologist
Plasma soluble VEGFR-1 is a potential dual biomarker of response and toxicity for bevacizumab with chemoradiation in locally advanced rectal cancer.
Abstract
Chen, Xuesi
Chinese Academy of Sciences
07/19/2013
3.89
Macromolecular bioscience
Effective tumor treatment by VEGF siRNA complexed with hydrophobic poly(amino acid)-modified polyethylenimine.
Abstract
Ribatti, D
11 Policlinico
04/19/2012
3.87
Genes and immunity
Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
Abstract
Chen, Xiaoyuan
National Institutes of Health (NIH)
07/01/2011
3.84
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging
Preclinical lymphatic imaging.
Abstract
Chen, Xiaoyuan
Stanford University School of Medicine
09/11/2008
3.84
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging
Quantitative PET imaging of VEGF receptor expression.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
10/09/2012
3.79
Atherosclerosis
Regulation of endothelial lipase and systemic HDL cholesterol levels by SREBPs and VEGF-A.
Abstract
Yla-Herttuala, Seppo
University of Eastern Finland
08/03/2011
3.79
Atherosclerosis
Adventitial gene transfer of VEGFR-2 specific VEGF-E chimera induces MCP-1 expression in vascular smooth muscle cells and enhances neointimal formation.
Abstract
Zhang, Yanbin
Xuzhou Medical College
11/22/2012
3.77
Circulation journal : official journal of the Japanese Circulation Society
Luteolin inhibits angiotensin II-induced human umbilical vein endothelial cell proliferation and migration through downregulation of Src and Akt phosphorylation.
Abstract
Zhang, Youcheng
Lanzhou University Second Hospital
11/25/2013
3.74
Cell biochemistry and biophysics
The value of expression of M2-PK and VEGF in patients with advanced gastric cancer.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
11/14/2011
3.73
The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research
The cutaneous vascular system in chronic skin inflammation.
Abstract
Chen, Xiang
Kagoshima University Graduate School of Medical and Dental Sciences
01/08/2010
3.72
Journal of dermatological science
CD147/basigin promotes progression of malignant melanoma and other cancers.
Abstract
Ylä-Herttuala, S
University of Eastern Finland
05/12/2011
3.71
Gene therapy
Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle.
Abstract
Ylä-Herttuala, S
University of Eastern Finland
02/12/2009
3.71
Gene therapy
Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
04/09/2010
3.71
American journal of physiology. Heart and circulatory physiology
VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
10/04/2010
3.68
Wiley interdisciplinary reviews. Systems biology and medicine
Systems biology of pro-angiogenic therapies targeting the VEGF system.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
11/07/2012
3.66
Investigative ophthalmology & visual science
Expression and role of VEGF--a in the ciliary body.
Abstract
McDonald, Denise M
Queen's University Belfast
10/03/2012
3.66
Investigative ophthalmology & visual science
eNOS overexpression exacerbates vascular closure in the obliterative phase of OIR and increases angiogenic drive in the subsequent proliferative stage.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
12/09/2011
3.66
Investigative ophthalmology & visual science
Expression and role of VEGF in the adult retinal pigment epithelium.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
08/29/2008
3.66
Investigative ophthalmology & visual science
Role of cell and matrix-bound VEGF isoforms in lens development.
Abstract
Van Cutsem, Eric
University of Chicago Comprehensive Cancer Center
05/05/2013
3.61
Targeted oncology
Role of targeted agents in metastatic colorectal cancer.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
03/13/2013
3.58
Experimental cell research
Molecular mechanisms and imaging of lymphatic metastasis.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
12/23/2010
3.58
Experimental cell research
Quantification and cell-to-cell variation of vascular endothelial growth factor receptors.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
06/23/2010
3.58
Experimental cell research
Thymus cell antigen 1 (Thy1, CD90) is expressed by lymphatic vessels and mediates cell adhesion to lymphatic endothelium.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
03/04/2009
3.58
Experimental cell research
Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functions.
Abstract
Chen, Xiaoyuan
Stanford University School of Medicine
06/23/2010
3.55
Current drug targets
Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy.
Abstract
Stacker, Steven A
Royal Melbourne Hospital
04/17/2013
3.52
Clinical & experimental metastasis
Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.
Abstract
Stacker, Steven A
Royal Melbourne Hospital
11/03/2012
3.52
Clinical & experimental metastasis
Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis.
Abstract
Dvorak, Harold F
Beth Israel Deaconess Medical Center and Harvard Medical School
06/13/2012
3.52
Clinical & experimental metastasis
Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
02/01/2011
3.52
Annals of medicine
Vascular endothelial growth factors in retinal and choroidal neovascular diseases.
Abstract
Luo, Yongzhang
Tsinghua University
06/01/2009
3.51
IUBMB life
Unraveling the mysteries of endostatin.
Abstract
Ellis, Lee M
The University of Texas MD Anderson Cancer Center
04/27/2009
3.50
Seminars in oncology
Targeting tumor angiogenesis.
Abstract
Luo, Yongzhang
Tsinghua University
12/08/2009
3.42
Biochemistry
The heparin binding motif of endostatin mediates its interaction with receptor nucleolin.
Abstract
Zhang, Yang
Fudan University Shanghai Cancer Center
08/11/2012
3.41
The Journal of thoracic and cardiovascular surgery
Pattern of lymphatic spread in thoracic esophageal squamous cell carcinoma: A single-institution experience.
Abstract
Zhang, Y
Institutes of Medical Sciences
05/18/2009
3.38
Neuroscience
An Ang1-Tie2-PI3K axis in neural progenitor cells initiates survival responses against oxygen and glucose deprivation.
Abstract
Ribatti, D
11 Policlinico
04/17/2009
3.38
Neuroscience
Nerve growth factor and its receptors TrkA and p75 are upregulated in the brain of mdx dystrophic mouse.
Abstract
Luo, Y
Sun Yat-Sen University
09/30/2012
3.38
Diabetes, obesity & metabolism
KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF.
Abstract
Luo, Y
Sun Yat-sen University
03/15/2012
3.38
Diabetes, obesity & metabolism
Effects of intravitreal injection of KH902, a vascular endothelial growth factor receptor decoy, on the retinas of streptozotocin-induced diabetic rats.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
05/08/2012
3.28
Journal of tissue engineering and regenerative medicine
Promotion of diabetic wound healing by collagen scaffold with collagen-binding vascular endothelial growth factor in a diabetic rat model.
Abstract
Motzer, Robert J
Pfizer Oncology, 10646 Science Center Drive, La Jolla, San Diego, CA, 92121
07/22/2013
3.26
Cancer journal (Sudbury, Mass.)
Novel approaches targeting the vascular endothelial growth factor axis in renal cell carcinoma.
Abstract
Kiefer, Friedemann
Max-Planck-Institute for Molecular Biomedicine
11/22/2011
3.24
Biochemical Society transactions
Intravital two-photon microscopy of lymphatic vessel development and function using a transgenic Prox1 promoter-directed mOrange2 reporter mouse.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
11/13/2009
3.24
Biochemical Society transactions
Gene therapy with vascular endothelial growth factors.
Abstract
Ruhrberg, Christiana
University College London
11/13/2009
3.24
Biochemical Society transactions
Neuropilin ligands in vascular and neuronal patterning.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
07/13/2013
3.21
Journal of vascular surgery
Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
11/21/2011
3.15
BMC systems biology
Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
09/03/2008
3.11
Cell and tissue research
VEGF inhibition: insights from preclinical and clinical studies.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
07/22/2008
3.11
Cell and tissue research
Lymphatic endothelium in health and disease.
Abstract
Wang, Yuping
Harbin Medical University
12/05/2013
3.05
The Journal of steroid biochemistry and molecular biology
Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells.
Abstract
Wang, Yifeng
Third Affiliated Hospital of Guangzhou Medical College
06/05/2012
3.05
American journal of reproductive immunology (New York, N.Y. : 1989)
The role of tissue factor and protease-activated receptor 2 in endometriosis.
Abstract
Zhang, Yongxue
Tongji Medical College of Huazhong University of Science and Technology
07/15/2012
3.02
Nuclear medicine and biology
Therapeutic gene expression in transduced mesenchymal stem cells can be monitored using a reporter gene.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
06/10/2010
3.02
European journal of clinical investigation
VEGF-DdeltaNdeltaC mediated angiogenesis in skeletal muscles of diabetic WHHL rabbits.
Abstract
Luo, Yongming
Jiangxi University of Traditional Chinese Medicine
06/07/2011
3.01
BMC cancer
In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cells.
Abstract
Cao, Yali
Jiangxi Breast Center Third Hospital of Nanchang
11/21/2013
2.93
Molecular biology reports
Silencing MAP3K1 expression through RNA interference enhances paclitaxel-induced cell cycle arrest in human breast cancer cells.
Abstract
Motzer, Robert J
Pfizer Oncology, 10646 Science Center Drive, La Jolla, San Diego, CA, 92121
11/13/2013
2.83
Cancer chemotherapy and pharmacology
Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma.
Abstract
Ribatti, Domenico
University of Bari Medical School
06/03/2011
2.83
Cancer chemotherapy and pharmacology
Vascular normalization: a real benefit?
Abstract
Zhang, Yafang
Mudanjiang Medical University
05/04/2011
2.83
Microvascular research
COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
Abstract
Zhang, Yafang
Mudanjiang Medical University
07/23/2011
2.83
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
08/22/2011
2.82
The International journal of developmental biology
From the discovery of vascular endothelial growth factor to the introduction of avastin in clinical trials - an interview with Napoleone Ferrara by Domenico Ribatti.
Abstract
Ylä-Herttuala, S
University of Eastern Finland
09/24/2010
2.80
Cancer gene therapy
Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice.
Abstract
Wang, Yaxu
Second Affiliated Hospital of Chongqing Medical University
01/09/2012
2.78
American journal of surgery
Expression of vascular endothelial growth factor-C in gastric carcinoma and the effect of its antisense gene transfection on the proliferation of human gastric cancer cell line SGC-7901.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
07/27/2010
2.75
Diabetes research and clinical practice
Acceleration of diabetic wound healing by collagen-binding vascular endothelial growth factor in diabetic rat model.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
04/07/2009
2.74
Physiological genomics
Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport.
Abstract
Motzer, Robert J
Pfizer Oncology, 10646 Science Center Drive, La Jolla, San Diego, CA, 92121
09/06/2011
2.64
Cancer
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma.
Abstract
Choueiri, Toni K
Stanford University School of Medicine
06/29/2011
2.64
Cancer
The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy.
Abstract
Sood, Anil K
University of Texas M.D. Anderson Cancer Center
12/19/2009
2.64
Cancer biology & therapy
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer.
Abstract
Mooney, David J
Harvard University
06/05/2012
2.60
Journal of periodontology
Guided bone regeneration using injectable vascular endothelial growth factor delivery gel.
Abstract
Ribatti, Domenico
University of Bari Medical School
01/12/2012
2.59
Histochemistry and cell biology
Neuropilin-1 is upregulated in Sjögren's syndrome and contributes to pathological neovascularization.
Abstract
Zhang, Yunhan
The First Affiliated Hospital of Zhengzhou University
11/06/2011
2.56
Journal of cancer research and clinical oncology
The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma.
Abstract
Choueiri, Toni K
Stanford University School of Medicine
07/03/2012
2.55
Current oncology reports
The double edged sword of bleeding and clotting from VEGF inhibition in renal cancer patients.
Abstract
Zhang, Yongbin
Ningxia Medical University
03/10/2013
2.52
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice.
Abstract
Zhang, Yufeng
Wuhan University
03/28/2011
2.51
Clinical oral implants research
Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endothelial growth factor protein delivery.
Abstract
Yoon, Young-sup
Emory University School of Medicine
06/26/2012
2.49
Trends in cardiovascular medicine
Role of bone marrow-derived lymphatic endothelial progenitor cells for lymphatic neovascularization.
Abstract
Kerbel, Robert S
University of Toronto
10/21/2011
2.49
Breast (Edinburgh, Scotland)
Reappraising antiangiogenic therapy for breast cancer.
Abstract
Ferrara, Napoleone
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080
04/08/2011
2.48
Biochemical and biophysical research communications
Comparing protein VEGF inhibitors: In vitro biological studies.
Abstract
Luo, Yongzhang
Tsinghua University
01/22/2009
2.48
Biochemical and biophysical research communications
Fibrinogen facilitates the anti-tumor effect of nonnative endostatin.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
03/20/2012
2.48
The journal of gene medicine
Endothelium-specific overexpression of human vascular endothelial growth factor-D in mice leads to increased tumor frequency and a reduced lifespan.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
01/24/2012
2.48
The journal of gene medicine
Baculovirus-mediated vascular endothelial growth factor-D(ΔNΔC) gene transfer induces angiogenesis in rabbit skeletal muscle.
Abstract
Wang, Yuping
Harbin Medical University
03/21/2011
2.44
Reproductive sciences (Thousand Oaks, Calif.)
Altered nephrin and podoplanin distribution is associated with disturbed polarity protein PARD-3 and PARD-6 expressions in podocytes from preeclampsia.
Abstract
Wang, Yuping
Harbin Medical University
06/15/2009
2.44
Reproductive sciences (Thousand Oaks, Calif.)
Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia.
Abstract
Wang, Yan
The General Hospital of Chinese People's Liberation Army
08/29/2012
2.43
Experimental and molecular pathology
Hypoxia inhibits the differentiation of mesenchymal stem cells into osteoblasts by activation of Notch signaling.
Abstract
Detmar, Michael
Swiss Federal Institute of Technology
10/16/2012
2.40
International journal of oncology
Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator.
Abstract
Zhang, Yingqi
Fourth Military Medical University
09/27/2013
2.35
BMC biotechnology
Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.
Abstract
Ylä-Herttuala, Seppo
University of Eastern Finland
04/20/2013
2.34
Gene
Cardiovascular gene therapy with vascular endothelial growth factors.
Abstract
Punt, Cornelis J A
Radboud University Nijmegen Medical Center
04/19/2010
2.32
Clinical therapeutics
Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review.
Abstract
Dai, Jianwu
Chinese Academy of Sciences
07/26/2009
2.32
Journal of materials science. Materials in medicine
Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold.
Abstract
Zhang, Yongzhen
Peking University Third Hospital and Key Laboratory of Cardiovascular Molecular Biology and Regulatory peptides
11/29/2012
2.22
Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Changes and significance of serum angiopoietin-2 levels in patients with coronary heart disease.
Abstract
Wang, Yiqiang
Shandong Academy of Medical Sciences
04/03/2013
2.21
Molecular vision
Profiling of genes associated with the murine model of oxygen-induced retinopathy.
Abstract
D'Amore, Patricia A
Schepens Eye Research Institute/Massachusett Eye and Ear
03/01/2012
2.21
Molecular vision
Molecular regulation of vascular endothelial growth factor expression in the retinal pigment epithelium.
Abstract
Bautch, Victoria L
The University of North Carolina at Chapel Hill
10/12/2011
2.20
Cells, tissues, organs
How blood vessel networks are made and measured.
Abstract
Ruhrberg, Christiana
University College London
10/04/2010
2.17
Organogenesis
VEGF in the nervous system.
Abstract
Cao, Ya
the Third Xiangya Hospital of Central SouthUniversity
05/01/2012
2.15
Journal of experimental & clinical cancer research : CR
In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4-2B prostate cancer cell line.
Abstract
Zhang, Yuan
Jinan University
01/10/2013
2.14
Medical oncology (Northwood, London, England)
The effect of Bcl-2 siRNA combined with miR-15a oligonucleotides on the growth of Raji cells.
Abstract
Ribatti, Domenico
University of Bari Medical School
03/14/2013
2.11
Regulatory peptides
In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment.
Abstract
Ribatti, Domenico
University of Bari Medical School
08/25/2011
2.11
Regulatory peptides
Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells.
Abstract
Ribatti, Domenico
University of Bari Medical School
04/10/2009
2.11
Regulatory peptides
Pro-angiogenic activity of Urotensin-II on different human vascular endothelial cell populations.
Abstract
Zhang, Yejia
Thomas Jefferson University
08/04/2010
2.08
Spine
Fibronectin splicing variants in human intervertebral disc and association with disc degeneration.
Abstract
Wang, Yunshan
Jinan Central Hospital Affiliated to Shandong University
05/05/2013
2.03
International orthopaedics
Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells.
Abstract
Popel, Aleksander S
Johns Hopkins University School of Medicine
11/09/2009
2.00
Methods in enzymology
Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models.
Abstract
Zhang, Yanmin
Xi'an Jiaotong University
06/19/2012
2.00
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
Ta1722, an anti-angiogenesis inhibitor targeted on VEGFR-2 against human hepatoma.
Abstract
Ribatti, Domenico
University of Bari Medical School
04/08/2010
2.00
Clinical and experimental medicine
VEGF expression and angiogenesis in oral squamous cell carcinoma: an immunohistochemical and morphometric study.
Abstract
Ribatti, Domenico
University of Bari Medical School
12/24/2009
2.00
Clinical and experimental medicine
VEGF-A/HGF induce Prox-1 expression in the chick embryo chorioallantoic membrane lymphatic vasculature.
Abstract
Ribatti, Domenico
University of Bari Medical School
10/31/2009
2.00
Clinical and experimental medicine
Intussusceptive microvascular growth in human glioma.
Abstract
A Novel Ex vivo Culture Method for the Embryonic Mouse Heart
A Novel Ex vivo Culture Method…
Microsurgical Clip Obliteration of Middle Cerebral Aneurysm Using Intraoperative Flow Assessment
Microsurgical Clip Obliteratio…
Aortic Ring Assay
Aortic Ring Assay…
Contrast Enhanced Vessel Imaging using MicroCT
Contrast Enhanced Vessel Imagi…
A Mouse Model of the Cornea Pocket Assay for Angiogenesis Study
A Mouse Model of the Cornea Po…
Doppler Optical Coherence Tomography of Retinal Circulation
Doppler Optical Coherence Tomo…
Imaging Leukocyte Adhesion to the Vascular Endothelium at High Intraluminal Pressure
Imaging Leukocyte Adhesion to …
Closed System Cell Culture Protocol Using HYPERStack Vessels with Gas Permeable Material Technology
Closed System Cell Culture Pro…
Isolation of Human Umbilical Arterial Smooth Muscle Cells (HUASMC)
Isolation of Human Umbilical A…
Intravital Microscopy of the Mouse Brain Microcirculation using a Closed Cranial Window
Intravital Microscopy of the M…
An in vivo Assay to Test Blood Vessel Permeability
An in vivo Assay to Test Blood…
JoVE subscription required to view articles
Related JoVE Videos